Abstract: A support assembly is configured to secure an object to a structure and includes a bracket adapted to be secured to the object. The bracket has an opening formed therein. The support assembly further includes a support capable of being received within the opening of the bracket in a secure position. The support has a marking element designed to extend away from the object when positioning the support within the opening of the bracket. The arrangement is such that when positioning the support within the opening of the bracket, the marking element forms a mark on the structure in response to positioning the object against the structure. The support assembly also includes a device to secure the support to the structure upon removing the support from the opening of the bracket with the marking element being positioned on the mark formed on the structure.

Abstract: This invention relates to progesterone receptor/ligand complex, and related methods and software systems. Methods for designing and/or selecting ligands of the progesterone receptor using the three-dimensional structural coordinates of the progesterone receptor and/or nonsteroidal ligands are disclosed.

Abstract: Cables including a plurality of twisted pairs of insulated conductors, a separator disposed among the plurality of twisted pairs so as to physically separate a first twisted pair from a second twisted pair, and a jacket surrounding the plurality of twisted pairs and the separator. The jacket may include a plurality of protrusions extending away from an inner circumferential surface of the jacket toward a center of the cable. The plurality of protrusions are configured so as to hold the plurality of twisted pairs away from the inner circumferential surface of the jacket, and may provide an air gap between the plurality of twisted pairs of insulated conductors and the inner circumferential surface of the jacket. In one example, a boundary of the air gap adjacent the inner circumferential surface of the jacket is arc shaped.

Abstract: According to one exemplary embodiment, a low harmonic switching device includes a first switching block including a first multi-gate FET, where the first switching block is coupled to a first input and a shared output of the low harmonic switching device. A first capacitor is coupled between a first gate and a source of the first multi-gate FET and a second capacitor is coupled between a second gate and a drain of the first multi-gate FET so as to cause a reduction in a harmonic amplitude in the shared output. A resistor can couple the source to the drain of the first multi-gate FET. The first switching block can further include a second multi-gate FET, where a source of the second multi-gate FET is coupled to the drain of the first multi-gate FET and a drain of the second multi-gate FET is coupled to the shared output.

Abstract: Systems and methods for digitally controlling sensors. In one embodiment, a digital controller for a capacitance diaphragm gauge is embedded in a digital signal processor (DSP). The controller receives digitized input from a sensor AFE via a variable gain module, a zero offset module and an analog-to-digital converter. The controller automatically calibrates the received input by adjusting the variable gain and zero offset modules. The controller also monitors and adjusts a heater assembly to maintain an appropriate temperature at the sensor. The controller utilizes a kernel module that allocates processing resources to the various tasks of a gauge controller module. The kernel module repetitively executes iterations of a loop, wherein in each iteration, all of a set of high priority tasks are performed and one of a set of lower priority tasks are performed. The controller module thereby provides sensor measurement output at precisely periodic intervals, while performing ancillary functions as well.

Abstract: A multi-port cabling system for use in installing cable to an equipment rack or enclosure or within an equipment room or data center includes a cabling assembly comprising at least one connector head having a plurality of ports and at least one cable operatively connected to the plurality of ports. The at least one cable terminates internally within the connector head to operatively couple the cable to the plurality of ports. The system further includes a mounting bracket. The mounting bracket and the connector head are each configured for tool-less attachment of one or more cabling assemblies to the bracket. The mounting bracket is further configured to removably mount to an equipment rack or enclosure, and/or to a wall, to thereby install one or more cables. The cabling assembly and the cabling system help to eliminate on-site cable termination and testing during installation of cables to rack-mounted equipment.

Abstract: A fully integrated, programmable mixed-signal radio transceiver comprising a radio frequency integrated circuit (RFIC) which is frequency and protocol agnostic with digital inputs and outputs, the radio transceiver being programmable and configurable for multiple radio frequency bands and standards and being capable of connecting to many networks and service providers. The RFIC includes a tunable resonant circuit that includes a transmission line having an inductance, a plurality of switchable capacitors configured to be switched into and out of the tunable resonant circuit in response to a first control signal, and at least one variable capacitor that can be varied in response to a second control signal, wherein a center resonant frequency of the resonant circuit is electronically tunable responsive to the first and second control signals that control a first capacitance value of the plurality of switchable capacitors and a second capacitance value of the at least one variable capacitor.

Abstract: The present invention disclosed recombinant anti-VLA-4 antibody molecules, including humanized recombinant anti-VLA-4 antibody molecules. These antibodies are useful in the treatment of specific and non-specific inflammation, including asthma and inflammatory bowel disease. In addition, the humanized recombinant anti-VLA-4 antibodies disclosed can be useful in methods of diagnosing and localizing sites of inflammation.

Abstract: The invention relates to an inflatable device comprising an electromechanical device and a self-sealing valve, and in particular, to any inflatable device that includes the assembly. In some embodiments, at least a portion of a fluid controller is coupled to and supported by an inflatable bladder of an inflatable device. The fluid controller may be located in a compartment, and the compartment may be within the profile of the bladder. The inflatable device may be a single bladder mattress or a dual bladder mattress. The inflatable device may include a heater or an articulation device. The inflatable device may be multi-positional device or have a storage compartment. The inflatable device may be configurable using one or more members such as a membrane or fasteners.

Abstract: A containment bracket is disclosed for encasing a cable or wire within an enclosure designed to house electrical components. The containment bracket includes a housing having an interior region, the housing being attached to the enclosure. The containment bracket further includes a door coupled to the housing to access the interior region of the housing. A method for encasing a cable or wire within an enclosure designed to house electrical components is further disclosed.

Abstract: The present invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of an anti-apoptotic gene, comprising a complementary RNA strand having a nucleotide sequence which is less that 25 nucleotides in length and which is substantially identical to at least a part of an apoptotic gene, such as a Bcl gene. The invention also relates to a pharmaceutical composition comprising the dsRNA together with a pharmaceutically acceptable carrier; methods for treating diseases caused by the expression of an anti-apoptotic gene using the pharmaceutical composition; and methods for inhibiting the expression of an anti-apoptotic gene in a cell.

Abstract: The present invention relates to a humanized antibody or functional fragment thereof which binds to a mammalian (e.g., human) CC-chemokine receptor 2 (CCR2) or a portion of the receptor and blocks binding of a ligand to the receptor. The invention further relates to a method of inhibiting the interaction of a cell bearing mammalian CCR2 with a ligand thereof, and to use of the antibodies and fragments in therapeutic, prophylactic and diagnostic methods.

Abstract: An apparatus for performing operations on a surface of an electronic substrate comprises a frame, a dispenser, coupled to the frame, to dispense a material onto the electronic substrate, a stencil moveable on a gantry system having at least one aperture to receive the material as the material is dispensed on the substrate, a controller that controls dispensing of the material on the substrate, and a wiper to remove material from the stencil as the stencil is translated away from the electronic substrate by the gantry system.

Abstract: The application discloses a belt formed of first and second portions of thermoplastic sheet including, respectively, first and second pluralities of tabs spaced apart so as to define first and second pluralities of openings along corresponding first and second edges of the first and second portions of thermoplastic sheet, wherein the first plurality of tabs are joined to the second plurality of tabs so as to join the first edge to the second edge.

Abstract: A self-starting fuel cell assembly and methods of starting fuel cells are disclosed. In at least certain examples, the fuel cell assembly can be configured to supply voltage to a fuel source, an air source or both. The fuel cell assembly further includes a control system configured to detect an output voltage of the fuel cell stack. The control system can be further configured to control at least one of the air source and the fuel source to control the output voltage in a working stage and in a start-up stage.

Abstract: A number of examples of insulated conductors having geometrically optimized shapes and form factors, that may be used in twisted-pair cables and other types of communication cable to enhance the performance of, and/or reduce the cost of manufacturing such cables.

Abstract: Fluorinated paracyclophane compounds represented by the formula where least one of R1 and R2 comprises a fluorinated moiety is disclosed. These compounds can be utilized as precursor dimer compounds to produce polymeric coatings comprising copolymers of trifluorinated paraxylylene.

Abstract: A stencil printer is provided for depositing solder paste onto a surface of an electronic substrate. The stencil printer includes a frame and a stencil coupled to the frame. The stencil has a plurality of apertures formed therein. The stencil printer further includes a dispenser coupled to the frame. The stencil and the dispenser are adapted to deposit solder paste onto the electronic substrate. The stencil printer further includes an imaging system constructed and arranged to capture an image of the electronic substrate. The imaging system includes a camera assembly, an on-axis illumination assembly adapted to generate light substantially along a first axis generally perpendicular to the surface of the electronic substrate, and an off-axis illumination assembly adapted to generate rays of light substantially along a second axis extending at an angle with respect to the first axis. A controller is coupled to the imaging system to control movement of the imaging system to capture an image.

Abstract: The present invention relates to the three dimensional solution structure of the N-terminal domain of TNFR-1 associated death domain protein (“N-TRADD”), as well as the identification and characterization of a C-TRAF2 binding active site of N-TRADD. Also provided for by the present invention are methods of utilizing the three dimensional structures for the design and selection of potent and selective inhibitors of TNF signaling pathways.